Modulating thrombotic potential in catheter-based percutaneous coronary and peripheral vascular interventions

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Vascular Surgery

Background:

• Thrombosis is an unavoidable complication of percutaneous vascular interventions.
• Procedures like angioplasty and stenting damage the intima, exposing thrombogenic subendothelium.
• This exposure triggers platelet activation and aggregation, leading to thrombus formation.

Purpose of the Study:

• To review the mechanisms of vascular thrombosis following percutaneous interventions.
• To highlight advances in pharmacological agents used to manage these thrombotic complications.

Main Methods:

• Review of existing literature on vascular thrombosis and percutaneous interventions.
• Analysis of the pathophysiological response to vascular injury.
• Evaluation of the efficacy of pharmacological agents in mitigating thrombotic events.

Main Results:

• Percutaneous interventions consistently lead to intimal damage and thrombosis.
• Thrombus formation can cause abrupt vessel closure, ischemia, and organ dysfunction.
• Pharmacological advancements have significantly reduced the incidence and severity of thrombotic complications.

Conclusions:

• Understanding thrombosis mechanisms is crucial for managing percutaneous intervention complications.
• Adjunctive pharmacological therapies are vital in preventing and treating thrombosis after interventions.
• Further research continues to improve patient outcomes by refining antithrombotic strategies.